These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9261128

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A mutated murine reduced folate carrier (RFC1) with increased affinity for folic acid, decreased affinity for methotrexate, and an obligatory anion requirement for transport function.
    Zhao R, Assaraf YG, Goldman ID.
    J Biol Chem; 1998 Jul 24; 273(30):19065-71. PubMed ID: 9668089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate.
    Zhao R, Assaraf YG, Goldman ID.
    J Biol Chem; 1998 Apr 03; 273(14):7873-9. PubMed ID: 9525881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines.
    Sharif KA, Moscow JA, Goldman ID.
    Biochem Pharmacol; 1998 May 15; 55(10):1683-9. PubMed ID: 9634005
    [Abstract] [Full Text] [Related]

  • 10. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R, Babani S, Gao F, Liu L, Goldman ID.
    Clin Cancer Res; 2000 Sep 15; 6(9):3687-95. PubMed ID: 10999762
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier.
    Sharina IG, Zhao R, Wang Y, Babani S, Goldman ID.
    Mol Pharmacol; 2001 May 15; 59(5):1022-8. PubMed ID: 11306683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased expression and genomic organization of a folate-binding protein homologous to the human placental isoform in L1210 murine leukemia cell lines with a defective reduced folate carrier.
    Brigle KE, Seither RL, Westin EH, Goldman ID.
    J Biol Chem; 1994 Feb 11; 269(6):4267-72. PubMed ID: 8307991
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine leukemia cell line.
    Brigle KE, Spinella MJ, Sierra EE, Goldman ID.
    J Biol Chem; 1995 Sep 29; 270(39):22974-9. PubMed ID: 7559435
    [Abstract] [Full Text] [Related]

  • 16. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G, Mauritz RM, Assaraf YG, Sprecher H, Drori S, Kathmann I, Westerhof GR, Priest DG, Bunni M, Pinedo HM, Schornagel JH, Peters GJ.
    Adv Enzyme Regul; 1997 Sep 29; 37():59-76. PubMed ID: 9381986
    [Abstract] [Full Text] [Related]

  • 17. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G, Mauritz R, Drori S, Sprecher H, Kathmann I, Bunni M, Priest DG, Noordhuis P, Schornagel JH, Pinedo HM, Peters GJ, Assaraf YG.
    J Biol Chem; 1998 Nov 13; 273(46):30189-98. PubMed ID: 9804775
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.